We introduce a mass spectrometry-based method that provides residue-resolved quantitative information about protein phosphorylation. in this assay we combined our full-length expressed stable isotope-labeled protein for quantification strategy (FleXiQuant) with a traditional kinase assay to determine the mechanisms of multikinase substrate phosphorylation such as priming-dependent kinase activities. the assay monitors the decrease in signal intensity of the substrate peptides and the concomitant increase in the (n × 80 da)-shifted phosphorylated peptide. We analyzed the c-Jun n-terminal kinase (JnK)-dependent glycogen synthase kinase 3b (GsK3b) activity on doublecortin (dcX) revealing mechanistic details about the role of phosphorylation cross-talk in GsK3b activity and permitting an advanced model for GsK3b-mediated signaling.
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Protein phosphorylation is one of the most studied molecular mecha nisms of the cell, yet the exact details of protein phosphorylationbased signaling mechanisms can be difficult to study for several reasons. For example, substrates are often phosphorylated by a combination of kinases, but kinase assays have yet to be coupled to a readout that can localize a phosphorylation event to a specific amino acid of a substrate and determine the extent of the phosphory lation. Traditionally, once candidate kinasesubstrate partners are inferred, biologists turn to an in vitro kinase assay for validation 1, 2 . However, information regarding the location and abundance of phosphorylation sites and the dependence on crosstalk between sites is not readily determined. One could investigate specific sites by immunodetection-based methods, but the use of antibodies to detect posttranslational modifications may be suboptimal owing to epitope occlusion, nonquantitative binding behavior and/or suboptimal sensitivity and specificity 3, 4 . To fully understand the mechanisms of kinase activity that regulate cells and their signaling cascades, we need to extract quantitative information on phosphory lation sites. Mass spectrometry-based phosphorylation analysis is currently the most efficient method to readily identify, localize and quantify many phosphorylation sites on a substrate in a single experiment [5] [6] [7] , but it is challenging to extract mechanistic details about kinase activities from standard mass spectrometry workflows. We designed a fulllength expressed stable isotope-labeled protein for quantification, called FLEXIQinase, a strategy that combines the power of soluble protein standards 7 and mass spectrometry, and is easily implemented into the wellestablished in vitro kinase assay workflow 1, 8 . To test its versatility, we analyzed serial kinase activi ties of the two kinases JNK and GSK3β on DCX 9 and uncovered a complex interaction of the kinases with their substrate.
results

Background
To demonstrate the application of FLEXIQinase to the relatively com plex analysis of the primingdependent kinase studies, we first outline the expected outcomes for the familiar onekinase assay scenario.
FleXiQinase for one-kinase assays
Traditionally, kinase activity is evidenced by the addition of 32 Plabeled phosphate to the candidate substrate and one uses an inactive form (or 'dead' kinase) as a control in a parallel experi ment 9 (Supplementary Fig. 1a ). FLEXIQinase adopts a similar, dead versus active kinase strategy, but the assay does not rely on the incorporation of 32 Fig. 1a) . Labeling of the control and phosphorylated substrate with different amino acid isotopologs allows for simultaneous sample processing before analysis by mass spectrometry. Mass spectrometry-based quantification results in three basic FLEXIQinase readouts (Supplementary Fig. 1b ): (i) no change in peak ratio of unphosphorylated peptides between samples, if the kinase does not phosphorylate a particular peptide; (ii) decreased or absent heavyion signal of the unphosphorylated peptide with respect to the light control indicates a phosphoryla tion event in the observed peptide; and this decrease in a heavy signal's intensity is accompanied by (iii) a concomitant increase in the ion signal of the heavy (+n × 80 Da)shifted phosphorylated peptide (n = number of phosphorylation sites).
FleXiQinase for serial kinase assays Some kinases require their substrates be primed by another kinase [10] [11] [12] ; in this case we used a twokinase assay with which addi tional peak pair patterns emerge (Fig. 1a) . First, unchanged peak ratios are no longer unique to unmodified peptides but can also represent phosphopeptides resulting from priming kinase activity only (Fig. 1a) . Second, phosphorylation by the second kinase can manifest itself by a decrease of the heavy peptide signal, an increase of a heavy phosphopeptide signal and/or the appearance of a heavy phosphopeptide peak without a light complement (Fig. 1b) .
These three scenarios reveal mechanistic details. A (phospho) peptide peak pair with no change in signal intensity indicates that the peptide is not phosphorylated by the second kinase (Fig. 1b) . A decrease in the heavy phosphopeptide peak signal intensity indicates an additional kinase 2-dependent phosphorylation on another site in the same peptide, which is associated with a concomitant increase or appearance of an n × 80 Da heavy phos phopeptide: the increased intensity of the heavy phosphopeptide signal indicates kinase 2-dependent additional phosphorylation on the same phosphorylation site also phosphorylated by kinase 1. The appearance of a heavyonly peak is the signature for a phosphopep tide with at least one kinase 2-specific phosphorylation site. These simple changes in the peptide peak ratios can therefore provide relevant details about kinase activities and specificities.
Peak chasing and insights into priming-dependent mechanisms
The peak ratio scenarios outlined above show that phosphopep tides can in turn serve as substrates for additional phosphorylation events. This results in the observation of various phosphorylated species for the same peptide, differing in retention time and in mass (+n × 80 Da) depending on the possible phosphorylation sites. We call the process of identifying substrate and product (phospho)peak pairs in the mass spectrum 'peak chasing' . The peak chase profile, that is, the extent of signal loss or gain, can vary among the peptides, indicating that a kinase can have different phosphorylation profiles on a single protein substrate.
To investigate the effects of prior priming phosphorylation events on subsequent kinase activities, FLEXIQinase experiments can be combined with sitedirected mutagenesis (Fig. 2) . Assume three phosphorylation sites (P1, P2 and P3) on two peptides: P1 and P2 on peptide A and P3 on peptide B. The second phosphory lation site (P2) is observed only after kinase 2 treatment (Fig. 2a) . The new phosphorylation site occurs on peptide A, whereas nothing changes on peptide B (control peptide ratio). Two kinase activity models can explain this observation (Fig. 2b) : (i) kinase 2 phosphorylated P2 without influence by primed P1 or P3, or (ii) kinase 2 activity was dependent on priming on P1 or P3. Sitedirected mutagenesis of P1 or P3 in combination with FLEXIQinase analysis will enable us to distinguish between the models. If a mutation does not perturb the substrate peptide ratios when compared to the wildtype substrate, it can be concluded that this site has no influence on kinase 2 activity. If, however, kinase 2-dependent phosphorylation on P2 is not observed after mutation, that is, the substrate peptide ratio is that of the control ratio, it can be concluded that this is the bona fide priming site (Fig. 2b) .
GsK3b phosphorylated the c-terminal end of dcX
We quantified peptide peak pairs corresponding to 80-90% of the DCX protein sequence and identified over 20 phosphorylation sites (Supplementary Table 1 ). Most of these sites were localized to the Cterminal domain spanning amino acids 299-340 (Fig. 3a) . The Nterminal half of DCX had unperturbed mixing ratios, indicating the absence of GSK3β activity. The phosphorylated peptides covering amino acids 299-340 displayed various mass spectrum peak pair ratios indicating that JNKinduced GSK3β activity was specific to the C terminus (Fig. 3a) .
JnK and GsK3b had several phosphorylation sites in common
The DCX sequence corresponding to amino acids 299-340 produced two tryptic peptides, each with unique peak chase No phosphorylation by either kinase Kinases 1 and 2 common sites Kinase 2-speci c combination P P P P P P P P P P P P P P P Or npg profiles (Fig. 3b) . In most cases, MS2 and/or MS3 spectra provided precise localization of the phosphorylation sites (Supplementary Table 1 ). The peakchase profile for peptide B showed that GSK3β phosphorylated this region and that activity was dependent on JNK priming, as indicated by the unchanged peak pair ratio for the unmodified peptide (Supplementary Fig. 2a) . The highest order phosphorylation product we observed was a triply phos phorylated peptide, and it had a higher heavy peak signal with respect to the light counterpart. This ratio indicates that for DCX, amino acids Ser327, Thr331 and Ser334 were target sites for both JNK and GSK3β. Thus, GSK3β phosphorylated these sites beyond the initial priming by JNK. However, phosphorylation by GSK3β was abrogated once particular doubly or triply phosphorylated species were generated (Fig. 3b) .
identification of new GsK3b target sites
The peak chase profile for the peptide cohort corresponding to DCX amino acids 299-323 (peptide A) was distinct from that of peptide B (Fig. 3b) , as we observed GSK3β activity irrespective of the priming status of peptide A (Fig. 3b) . The intensity of the heavy unmodified peptide signal was low, suggesting that prim ing in this aminoacid range was not a requirement for GSK3β activity. We did not observe the heavy peak until we obtained a triply phosphorylated peptide; the relative peak height of the cor responding light peptide was less than 1%, indicating that GSK3β activity heavily favored the formation of a triply phosphorylated species. We determined the triply phosphorylated peptide to be pSer316pSer317Gln318Leu319Ser320pT321 (in which 'p' indicates a phosphorylation site) corresponding to unexpected Figure 2 | A theoretical approach to interpreting a serial kinase mechanism. (a) Schematic of phosphorylation profile imprinted by the serial activity of kinases 1 and 2; possible phosphorylation sites are labeled 1, 2 and 3 (top). Illustration of resulting substrate and product peak profiles, which shows a decrease in the abundance of peptide A substrate only (bottom). (b) Schematic of two theoretical phosphorylation profiles that could be due to the mutation in the candidate priming site 1 (top). Illustration of substrate and product profiles that would arise from each possible phosphorylation profile (bottom). 'x', peptide peak not observed. Phosphorylation by kinases 1 and 2 is indicated by red and yellow circles, respectively.
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GSK3βspecific sites. The ability of GSK3β to phosphorylate nonprimed peptide A sequence was most likely due to the priming of amino acids downstream in peptide B, but other mechanisms may also be active, such as direct binding of GSK3β in peptide A (Supplementary Fig. 2a) , irrespective of priming status. Site directed mutagenesis experiments will assist in distinguishing among the models.
GsK3b -specific activity was dependent on downstream priming
To test whether GSK3βspecific activity on the SSxxxT motif depended on remote effects of the downstream (peptide B) priming status, we mutated the proposed priming region by sub stituting one (Thr331, Supplementary Fig. 3 ) or two (Ser327 and Thr331, Fig. 3c ) assumed priming sites with alanine. If the GSK3βspecific activity on the peptide A motif, SSxxxT, was dependent on the overall extent of phosphorylation of the pro posed priming region on peptide B, we would expect mutation dependent attenuated activity by GSK3β on this region. Results of experiments with the double mutant showed two major effects: the highestorder phosphopeptide we could readily capture for peptide B was a doubly phosphorylated form rather than the triply phosphorylated form observed in wildtype DCX (Fig. 3b) . In contrast, GSK3β activity on the sequence SSxxxT of peptide A was attenuated as a function of these mutations ( Fig. 3c and Supplementary Fig. 3 ), confirming that GSK3β activity on peptide A was dependent on these remote priming events (Supplementary Fig. 2b ). The effect observed for the single mutant was less than that of the double mutant, indicating that the extent of remote, downstream priming could modulate GSK3β activity (Supplementary Fig. 3 ).
pt321 phosphorylation status could drive priming response Based on the data above, we hypothesized that GSK3βspecific activity was influenced by more than one mechanism. This notion is underscored by the observation that phosphopeptides of peptide A harboring a JNKprimed pThr321, a previously described in vivo JNK phosphorylation site 13 , were also phos phorylated by GSK3β, irrespective of the mutation status down stream ( Fig. 3c and Supplementary Fig. 3 ). These data reveal that Thr321 is part of the priming hot spot that promotes GSK3β activity to the upstream SSxxxT motif. Relative abundance of pThr321 relative to the other singly phosphorylated peptide forms provided by JNK priming was rather low (<<10% of the total light population; Supplementary Fig. 4 ). Upon removal of downstream priming sites, GSK3β dependent activity relied more on the lowabundance pThr321, which might explain why we did not observe the final pSer316pSer317Gln318Leu319Ser320 pT321 form in the DCX mutants.
The mutant analyses suggest that even for wildtype DCX, a primed Thr321 is sufficient to trigger GSK3βspecific activ ity, giving rise to an 'immediate priming' response (Fig. 4) . However, the relatively low abundance of pT321 observed in our quantitative analysis of wildtype DCX ( Supplementary Fig. 4) , also indicates that GSK3βspecific activity is most likely driven by binding to and subsequent phos phorylation of the downstream amino acids, performing a type of 'secondary priming' in response to initial JNK priming (Fig. 4) . If these serine and/or threonine sites are removed, we are less likely to observe the GSK3βspecific phosphopeptide, indicating that secondary priming by GSK3β accounts for most of its pSer316 pSer317Gln318Leu319Ser320pT321 in the in vitro system. discussion Studying mechanistic details of primingdependent kinases is crucial to understanding the basic biology of these kinases and to design inhibitors. FLEXIQinase allows the qualitative and quanti tative analysis of a single kinase target with multiple acceptor sites, as are often observed in highthroughput mass spectrometrybased kinase screens 5, 6, 14 . FLEXIQinase can also serve as a follow up study on kinasesubstrate pairs identified in kinase screens. Once one has determined the phosphorylation dynamics in the controlled environment of the in vitro system, specific phos phopeptides of interest can be monitored and absolute quantifi cation can be determined in vivo [14] [15] [16] . Moreover, FLEXIQinase can be readily adapted to more complex in vivo experiments. We anticipate that FLEXIQinase will serve as a basis for even more sophisticated applications of the peakchasing strategy while remaining a simple and practical approach. By combining multi plexed labeling and FLEXIQinase, for example, detailed kinetic information about the phosphorylation site dynamics can be obtained in temporal experiments. The general approach is not limited to a single modification such as phosphorylation, and can be extended to several other posttranslational modifications and combinations thereof. 
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